Bock, C., Halbritter, F., Carmona, F. J., Tierling, S., Datlinger, P., Assenov, Y., Berdasco, M., Bergmann, A. K., Booher, K., Busato, F., Campan, M.
, Dahl, C., Dahmcke, C. M., Diep, D., Fernández, A. F., Gerhauser, C., Haake, A., Heilmann, K., Holcomb, T. ... Zhang, K. (2016).
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.
Nature Biotechnology,
34(7), 726-737.
https://doi.org/10.1038/nbt.3605
Brøsen, K.
, Andersen, S. E., Borregaard, J.
, Christensen, H. R., Christensen, P. M.
, Dalhoff, K. P., Damkier, P., Hallas, J., Heisterberg, J.
, Jessen, N., Jürgens, G., Kampmann, J. P. K.
, Laursen, B. E., Laursen, T., Nielsen, L. P., Poulsen, B. K., Poulsen, H. E.
, Andersen, L. V., Senderovitz, T. & Sonne, J. (2016).
Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality.
Basic & Clinical Pharmacology & Toxicology,
119(6), 523-532.
https://doi.org/10.1111/bcpt.12681
Cabrera, S. M., Wang, X., Chen, Y.-G., Jia, S., Kaldunski, M. L., Greenbaum, C. J., Mandrup-Poulsen, T., Hessner, M. J., Type 1 Diabetes TrialNet Canakinumab Study Group
& Rungby, J. (2016).
Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.
European Journal of Immunology,
46(4), 1030-1046.
https://doi.org/10.1002/eji.201546005